Revance Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $41M | 4.6M | 8.79 |
| 2023-09-30 | $53M | 4.6M | 11.47 |
| 2023-06-30 | $119M | 4.7M | 25.31 |
| 2023-03-31 | $162M | 5.1M | 32.07 |
| 2022-12-31 | $93M | 5.0M | 18.46 |
| 2022-06-30 | $92M | 6.7M | 13.82 |
| 2022-03-31 | $135M | 6.8M | 19.73 |
| 2021-12-31 | $122M | 6.9M | 17.65 |
| 2021-03-31 | $124M | 4.4M | 27.95 |
| 2020-12-31 | $123M | 4.3M | 28.34 |
| 2020-09-30 | $105M | 4.1M | 25.71 |
| 2020-06-30 | $98M | 4.0M | 24.42 |
| 2020-03-31 | $58M | 3.9M | 14.80 |
| 2019-12-31 | $65M | 4.0M | 16.22 |
| 2019-09-30 | $35M | 2.7M | 13.00 |
| 2019-06-30 | $31M | 2.5M | 12.63 |
| 2019-03-31 | $61M | 3.9M | 15.76 |
| 2018-12-31 | $77M | 3.8M | 20.13 |
| 2018-09-30 | $91M | 3.6M | 24.85 |
| 2018-06-30 | $101M | 3.7M | 27.45 |
| 2018-03-31 | $106M | 3.4M | 30.80 |
| 2017-12-31 | $127M | 3.6M | 35.75 |
| 2017-06-30 | $96M | 3.6M | 26.40 |
| 2017-03-31 | $72M | 3.5M | 20.80 |
| 2016-12-31 | $71M | 3.4M | 20.70 |
| 2016-09-30 | $53M | 3.3M | 16.21 |
| 2016-06-30 | $45M | 3.3M | 13.60 |
| 2016-03-31 | $53M | 3.0M | 17.46 |
| 2015-12-31 | $100M | 2.9M | 34.16 |
| 2015-09-30 | $42M | 1.4M | 29.76 |
| 2015-06-30 | $45M | 1.4M | 31.99 |
| 2015-03-31 | $25M | 1.2M | 20.73 |
| 2014-12-31 | $12M | 722k | 16.94 |
| 2014-09-30 | $15M | 791k | 19.33 |
| 2014-06-30 | $23M | 676k | 34.00 |
| 2014-03-31 | $8.5M | 269k | 31.51 |